{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:47:33Z","timestamp":1790740053926,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T00:00:00Z","timestamp":1414022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00277-014-2227-5","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T05:09:28Z","timestamp":1413954568000},"page":"431-436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Post-therapy 18F-fluorodeoxyglucose positron emission tomography for predicting outcome in patients with peripheral T cell lymphoma"],"prefix":"10.1007","volume":"94","author":[{"given":"Naoto","family":"Tomita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukako","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chizuko","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Takasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rika","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ukihide","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Ishigatsubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,23]]},"reference":[{"key":"2227_CR1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","volume":"13","author":"T R\u00fcdiger","year":"2002","unstructured":"R\u00fcdiger T, Weisenburger DD, Anderson JR et al (2002) Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin\u2019s Lymphoma Classification Project. Ann Oncol 13:140\u20139","journal-title":"Ann Oncol"},{"key":"2227_CR2","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D et al (2008) International T-cell lymphoma project. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26:4124\u201330","journal-title":"J Clin Oncol"},{"key":"2227_CR3","doi-asserted-by":"crossref","unstructured":"[No authors listed] [2000] The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int 50:696\u2013702","DOI":"10.1046\/j.1440-1827.2000.01108.x"},{"key":"2227_CR4","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","volume":"117","author":"DD Weisenburger","year":"2011","unstructured":"Weisenburger DD, Savage KJ, Harris NL et al (2011) Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood 117:3402\u20138","journal-title":"Blood"},{"key":"2227_CR5","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/cncr.22507","volume":"109","author":"N Tomita","year":"2007","unstructured":"Tomita N, Motomura S, Hyo R et al (2007) Comparison of peripheral T-cell lymphomas and diffuse large B-cell lymphoma. Cancer 109:1146\u201351","journal-title":"Cancer"},{"key":"2227_CR6","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1182\/blood-2010-02-270785","volume":"116","author":"N Schmitz","year":"2010","unstructured":"Schmitz N, Tr\u00fcmper L, Ziepert M et al (2010) Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group. Blood 116:3418\u201325","journal-title":"Blood"},{"key":"2227_CR7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1200\/JCO.2006.08.2305","volume":"25","author":"ME Juweid","year":"2007","unstructured":"Juweid ME, Stroobants S, Hoekstra OS et al (2007) Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 25:571\u20138","journal-title":"J Clin Oncol"},{"key":"2227_CR8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME et al (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579\u201386","journal-title":"J Clin Oncol"},{"key":"2227_CR9","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1182\/blood-2005-01-0272","volume":"106","author":"C Haioun","year":"2005","unstructured":"Haioun C, Itti E, Rahmouni A et al (2005) 18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood 106:1376\u201381","journal-title":"Blood"},{"key":"2227_CR10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2005-06-2252","volume":"107","author":"M Hutchings","year":"2006","unstructured":"Hutchings M, Loft A, Hansen M et al (2006) FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood 107:52\u20139","journal-title":"Blood"},{"key":"2227_CR11","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1200\/JCO.2007.11.6525","volume":"25","author":"A Gallamini","year":"2007","unstructured":"Gallamini A, Hutchings M, Rigacci L et al (2007) Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin\u2019s lymphoma: a report from a joint Italian-Danish study. J Clin Oncol 25:3746\u201352","journal-title":"J Clin Oncol"},{"key":"2227_CR12","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2967\/jnumed.107.042093","volume":"48","author":"C Lin","year":"2007","unstructured":"Lin C, Itti E, Haioun C et al (2007) Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis. J Nucl Med 48:1626\u201332","journal-title":"J Nucl Med"},{"key":"2227_CR13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2967\/jnumed.108.057703","volume":"50","author":"E Itti","year":"2009","unstructured":"Itti E, Lin C, Dupuis J et al (2009) Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4\u00a0cycles of chemotherapy. J Nucl Med 50:527\u201333","journal-title":"J Nucl Med"},{"key":"2227_CR14","first-page":"1622","volume":"47","author":"M Hadithi","year":"2006","unstructured":"Hadithi M, Mallant M, Oudejans J et al (2006) 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease. J Nucl Med 47:1622\u20137","journal-title":"J Nucl Med"},{"key":"2227_CR15","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1080\/10428190701344915","volume":"48","author":"S Bishu","year":"2007","unstructured":"Bishu S, Quigley JM, Schmitz J et al (2007) F-18-fluoro-deoxy-glucose positron emission tomography in the assessment of peripheral T-cell lymphomas. Leuk Lymphoma 48:1531\u20138","journal-title":"Leuk Lymphoma"},{"key":"2227_CR16","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/annonc\/mdm265","volume":"18","author":"S Kako","year":"2007","unstructured":"Kako S, Izutsu K, Ota Y et al (2007) FDG-PET in T-cell and NK-cell neoplasms. Ann Oncol 18:1685\u201390","journal-title":"Ann Oncol"},{"key":"2227_CR17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3816\/CLM.2008.n.010","volume":"8","author":"D Karantanis","year":"2008","unstructured":"Karantanis D, Subramaniam RM, Peller PJ et al (2008) The value of [(18)F]fluorodeoxyglucose positron emission tomography\/computed tomography in extranodal natural killer\/T-cell lymphoma. Clin Lymphoma Myeloma 8:94\u20139","journal-title":"Clin Lymphoma Myeloma"},{"key":"2227_CR18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00277-008-0494-8","volume":"87","author":"PL Khong","year":"2008","unstructured":"Khong PL, Pang CB, Liang R et al (2008) Fluorine-18 fluorodeoxyglucose positron emission tomography in mature T-cell and natural killer cell malignancies. Ann Hematol 87:613\u201321","journal-title":"Ann Hematol"},{"key":"2227_CR19","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2967\/jnumed.108.053355","volume":"49","author":"C Suh","year":"2008","unstructured":"Suh C, Kang YK, Roh JL et al (2008) Prognostic value of tumor 18\u00a0F-FDG uptake in patients with untreated extranodal natural killer\/T-cell lymphomas of the head and neck. J Nucl Med 49:1783\u20139","journal-title":"J Nucl Med"},{"key":"2227_CR20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MNM.0b013e32833310fa","volume":"31","author":"HB Wu","year":"2010","unstructured":"Wu HB, Wang QS, Wang MF et al (2010) Utility of 18F-FDG PET\/CT for staging NK\/T-cell lymphomas. Nucl Med Commun 31:195\u2013200","journal-title":"Nucl Med Commun"},{"key":"2227_CR21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11899-011-0098-6","volume":"6","author":"PL Zinzani","year":"2011","unstructured":"Zinzani PL (2011) PET in T-cell lymphoma. Curr Hematol Malig Rep 6:241\u20134","journal-title":"Curr Hematol Malig Rep"},{"key":"2227_CR22","doi-asserted-by":"crossref","unstructured":"[No authors listed] [1993] A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. N Engl J Med 329:987\u201394","DOI":"10.1056\/NEJM199309303291402"},{"key":"2227_CR23","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","volume":"103","author":"A Gallamini","year":"2004","unstructured":"Gallamini A, Stelitano C, Calvi R et al (2004) Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 103:2474\u20139","journal-title":"Blood"},{"key":"2227_CR24","doi-asserted-by":"crossref","unstructured":"Tomita N, Kodama F, Tsuyama N et al (2014) Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma. Hematol Oncol (in press)","DOI":"10.1002\/hon.2136"},{"key":"2227_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM199807023390104","volume":"339","author":"TP Miller","year":"1998","unstructured":"Miller TP, Dahlberg S, Cassady JR et al (1998) Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin\u2019s lymphoma. N Engl J Med 339:21\u20136","journal-title":"N Engl J Med"},{"key":"2227_CR26","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B et al (1999) Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas NCI sponsored international working group. J Clin Oncol 17:1244\u201353","journal-title":"J Clin Oncol"},{"key":"2227_CR27","first-page":"1462","volume":"42","author":"T Tsuruo","year":"1982","unstructured":"Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1982) 4\u2032 -O-tetrahydropyranyladriamycin as a potential new antitumor agent. Cancer Res 42:1462\u20137","journal-title":"Cancer Res"},{"key":"2227_CR28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1182\/asheducation-2011.1.515","volume":"2011","author":"KJ Savage","year":"2011","unstructured":"Savage KJ (2011) Therapies for peripheral T-cell lymphomas. Hematology Am Soc Hematol Educ Program 2011:515\u201324","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2227_CR29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1532\/IJH97.03147","volume":"81","author":"M Mori","year":"2005","unstructured":"Mori M, Kitamura K, Masuda M et al (2005) Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin\u2019s lymphoma. Int J Hematol 81:246\u201354","journal-title":"Int J Hematol"},{"key":"2227_CR30","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/annonc\/mdq415","volume":"22","author":"X Cahu","year":"2011","unstructured":"Cahu X, Bodet-Milin C, Brissot E et al (2011) 18F-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T\/NK lymphomas: a study from the GOELAMS group. Ann Oncol 22:705\u201311","journal-title":"Ann Oncol"},{"key":"2227_CR31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2967\/jnumed.112.110262","volume":"54","author":"YJ Li","year":"2013","unstructured":"Li YJ, Li ZM, Xia XY et al (2013) Prognostic value of interim and posttherapy 18F-FDG PET\/CT in patients with mature T-cell and natural killer cell lymphomas. J Nucl Med 54:507\u201315","journal-title":"J Nucl Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2227-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-014-2227-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2227-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T13:13:29Z","timestamp":1565961209000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-014-2227-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,23]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["2227"],"URL":"https:\/\/doi.org\/10.1007\/s00277-014-2227-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,23]]}}}